Litcius/Paper detail

Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma

Anna L. Parks, Swetha Kambhampati, Bita Fakhri, Charalambos Andreadis, Lissa Gray, Sandy W. Wong, Nina Shah, Margaret C. Fang

2020Leukemia & lymphoma/Leukemia and lymphoma20 citationsDOIOpen Access PDF

Abstract

(2021). Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. Leukemia & Lymphoma: Vol. 62, No. 4, pp. 1003-1006.

Topics & Concepts

Chimeric antigen receptorMedicineVenous thrombosisMultiple myelomaLymphomaIncidence (geometry)AntigenThrombosisImmunologyInternal medicineOncologyCancer researchImmunotherapyCancerOpticsPhysicsCAR-T cell therapy researchLymphoma Diagnosis and TreatmentVenous Thromboembolism Diagnosis and Management
Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma | Litcius